A N

Chronolife is developing a unique solution capable of constant monitoring of multiple physiological parameters simultaneously that makes predictions based on big data analysis in real-time. Thanks to its disruptive proprietary algorithm, named HOTS (Hierarchy of Event-Based Time Surfaces), Chronolife aims to create a paradigm shift in themanagement of patients with chronic conditions. The company has chosen to initially target two major indications that affect a large number of patients worldwide: Heart Failure and Epilepsy.